Comparison of Antidiabetic Medications during the Treatment of Atherosclerosis in T2DM Patients

Table 1

Metabolic group parameters of patients at the beginning and at the end of the study.

Parameters	Beginning ()	End ()	P
FBG (mmol/L)	7.54 ± 1.77	7.00 ± 1.25	0.04
SBP (mmHg)	131.36 ± 15.25	131.46 ± 14.27	0.97
HbA1c (%)	6.80 ± 0.99	6.46 ± 0.77	0.03
BMI (kg/m^2)	28.35 ± 2.19	27.91 ± 1.99	0.20
TC (mmol/L)	4.69 ± 0.91	4.51 ± 0.75	0.19
TG (mmol/L)	2.19 ± 1.82	2.03 ± 1.33	0.55
NHDL (mmol/L)	3.75 ± 0.91	3.47 ± 0.77	0.06
HDL (mmol/L)	0.99 ± 0.21	1.03 ± 0.18	0.29
LDL (mmol/L)	2.75 ± 0.78	2.57 ± 0.82	0.21
UA (μmol/L)	336.29 ± 90.55	324.77 ± 92.08	0.44
IMT (mm)	1.22 ± 0.14	1.16 ± 0.14	0.07
Cr (μmol/L)	84.90 ± 14.18	85.96 ± 14.43	0.65
IL-6 (pg/mL)	14.59 ± 5.95	12.63 ± 5.45	0.04
ADPN (ng/mL)	12.18 ± 3.79	13.06 ± 3.80	0.16